28 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... Disease in HIV-AIDS ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... Disease in HIV-AIDS ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
Blurry vision in a patient with HIV/AIDS
Anterior Segment:
 • Herpes zoster ophthalmicus
 • Keratitis (HSV, Staph,
a patient with HIV ... /AIDS Anterior ... Acanthameoba, Candida ... seen with lower CD4 ... Anterior #Posterior #Differential
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Infections in HIV-AIDS ... Penicilliosis #IDSA ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... Women with in HIV-AIDS ... HumanPapillomavirus #IDSA ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
/ AIDS - Differential ... CNS Opportunistic ... • CNS opportunistic ... CNS #Infections #differential ... #diagnosis #AIDS
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... Encephalitis in HIV-AIDS ... patients with CD4 ... Prevention #Treatment #opportunistic ... #pharmacology
Pulmonary Infections in HIV-AIDS
Bacterial: 
 • No organism identified, Strep pneumoniae, H. influenzae, S.aureus, Streptococcus Grp
Infections in HIV-AIDS ... < 200: CMV, HSV ... > 200: Pulm embolism ... diagnosis #evaluation #differential ... #CD4
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Candidiasis in HIV-AIDS ... #Candidiasis #candida ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Infections in HIV-AIDS ... difficile Infection (CDI ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology